US Stock MarketDetailed Quotes

RGC Regencell Bioscience

Watchlist
  • 34.340
  • +5.330+18.37%
Close Apr 28 16:00 ET
  • 34.900
  • +0.560+1.63%
Post 20:01 ET
446.86MMarket Cap-104.06P/E (TTM)

Regencell Bioscience Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Dec 31, 2017
(Q4)Dec 31, 2017
(Q3)Sep 30, 2017
(Q2)Jun 30, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.37%-4M
5.77%-4.96M
-586.43%-5.27M
-5.61%-767.31K
-85.83%-726.57K
-390.99K
Net income from continuing operations
28.03%-4.36M
20.18%-6.06M
-463.92%-7.59M
-65.78%-1.35M
-107.77%-812.37K
---390.99K
-34.13%112.3M
-46.38%28.9M
-73.05%11.4M
-29.76%23.6M
Operating gains losses
----
--1.42K
----
----
----
----
66.32%-6.4M
75.00%-1.1M
-100.00%-16.8M
69.00%-3.1M
Depreciation and amortization
-3.13%745.59K
27.35%769.69K
2,184.54%604.4K
178.02%26.46K
--9.52K
--0
8.24%249.7M
6.54%63.5M
6.67%62.4M
10.54%62.9M
Deferred tax
----
----
----
----
----
----
-125.00%-600K
-98.11%100K
311.76%7M
-700.00%-3.2M
Other non cash items
-190.40%-248K
-695.68%-85.4K
---10.73K
----
----
----
4.38%14.3M
5.88%3.6M
2.70%3.8M
0.00%3.5M
Change In working capital
-15.02%-585.37K
50.30%-508.95K
-285.19%-1.02M
624.91%552.98K
--76.28K
--0
31.16%-46.4M
85.23%32.6M
67.67%-32.3M
-220.35%-148M
-Change in receivables
----
----
----
----
----
----
---27.7M
---111.3M
107.55%22M
-341.86%-38M
-Change in inventory
----
----
----
----
----
----
-186.67%-1.3M
325.00%900K
-70.00%600K
-300.00%-400K
-Change in prepaid assets
-269.01%-85.42K
77.88%-23.15K
-1,237.23%-104.63K
58.20%-7.82K
---18.72K
--0
-44.00%-3.6M
-28.33%4.3M
4,300.00%4.2M
-252.38%-7.4M
-Change in payables and accrued expense
-1,961.26%-34.88K
100.38%1.87K
-187.20%-489.03K
490.32%560.8K
--95K
--0
115.65%6.7M
16.45%106.2M
70.31%-21.2M
-2,203.03%-76M
-Change in other current liabilities
4.63%-465.07K
-13.30%-487.67K
---430.42K
--0
--0
----
----
----
----
----
-Change in other working capital
----
----
----
----
----
----
13.14%-20.5M
-0.31%32.5M
7.56%-37.9M
19.14%-26.2M
Cash from discontinued investing activities
Operating cash flow
19.37%-4M
5.77%-4.96M
-586.43%-5.27M
-5.61%-767.31K
-85.83%-726.57K
---390.99K
-0.15%409.9M
-5.10%154.3M
425.27%47.8M
-172.07%-41.8M
Investing cash flow
Cash flow from continuing investing activities
8,789.12%5.24M
100.55%58.98K
-10.78M
0
-117.84K
0
Capital expenditure reported
----
----
----
----
----
----
-16.52%-250.4M
-25.25%-74.9M
-8.37%-71.2M
-2.23%-59.6M
Net PPE purchase and sale
79.65%-5.38K
96.62%-26.42K
---780.88K
--0
---117.84K
--0
----
----
----
----
Net business purchase and sale
----
----
----
----
----
----
-1,164.23%-173.2M
290.00%9.5M
90.00%-400K
-4,415.00%-180.6M
Net investment purchase and sale
6,045.20%5.25M
100.85%85.4K
---10M
--0
--0
----
----
----
--10.3M
--0
Net other investing changes
----
----
----
----
----
----
828.57%13M
-7,400.00%-7.3M
--8.5M
--0
Cash from discontinued investing activities
Investing cash flow
8,789.12%5.24M
100.55%58.98K
---10.78M
--0
---117.84K
--0
-83.63%-410.6M
-12.36%-72.7M
24.25%-52.8M
-285.55%-240.2M
Financing cash flow
Cash flow from continuing financing activities
-24.19%102.28K
-99.40%134.91K
4,995.12%22.41M
-55.50%439.75K
105.43%988.08K
480.99K
Net issuance payments of debt
--0
--0
-170.58%-431.97K
-38.06%612.06K
105.43%988.08K
--480.99K
682.95%126.5M
-65.96%-7.8M
8.57%-6.4M
4,829.03%146.6M
Net common stock issuance
--0
--0
--22.67M
--0
--0
----
----
----
----
----
Cash dividends paid
----
----
----
----
----
----
0.00%-138.9M
0.00%-34.5M
-0.29%-34.6M
0.00%-34.5M
Net other financing activities
-24.19%102.28K
-17.74%134.91K
195.18%164K
---172.31K
----
----
-866.67%-4.6M
--0
--0
-270.00%-3.4M
Cash from discontinued financing activities
Financing cash flow
-24.19%102.28K
-99.40%134.91K
4,995.12%22.41M
-55.50%439.75K
105.43%988.08K
--480.99K
89.38%-17M
-10.44%-42.3M
-0.99%-41M
405.34%108.7M
Net cash flow
Beginning cash position
-75.61%1.56M
10,700.66%6.42M
-84.65%59.41K
59.05%386.98K
58.71%243.31K
--153.3K
12.25%246.5M
1.39%189.5M
-18.26%235.5M
24.63%408.8M
Current changes in cash
128.17%1.34M
-175.01%-4.77M
2,040.86%6.36M
-328.00%-327.57K
59.63%143.67K
--90K
-165.80%-17.7M
-34.06%39.3M
54.55%-46M
-334.34%-173.3M
Effect of exchange rate changes
164.01%53.22K
---83.15K
--0
--0
----
----
----
----
----
----
End cash Position
89.24%2.96M
-75.61%1.56M
10,700.66%6.42M
-84.65%59.41K
59.05%386.98K
--243.31K
-7.18%228.8M
-7.18%228.8M
1.39%189.5M
-18.26%235.5M
Free cash flow
19.70%-4.01M
17.49%-4.99M
-688.20%-6.05M
9.13%-767.31K
-115.97%-844.41K
---390.99K
-18.46%159.5M
-22.76%79.4M
58.66%-23.4M
-33,700.00%-101.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Dec 31, 2017(Q4)Dec 31, 2017(Q3)Sep 30, 2017(Q2)Jun 30, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.37%-4M5.77%-4.96M-586.43%-5.27M-5.61%-767.31K-85.83%-726.57K-390.99K
Net income from continuing operations 28.03%-4.36M20.18%-6.06M-463.92%-7.59M-65.78%-1.35M-107.77%-812.37K---390.99K-34.13%112.3M-46.38%28.9M-73.05%11.4M-29.76%23.6M
Operating gains losses ------1.42K----------------66.32%-6.4M75.00%-1.1M-100.00%-16.8M69.00%-3.1M
Depreciation and amortization -3.13%745.59K27.35%769.69K2,184.54%604.4K178.02%26.46K--9.52K--08.24%249.7M6.54%63.5M6.67%62.4M10.54%62.9M
Deferred tax -------------------------125.00%-600K-98.11%100K311.76%7M-700.00%-3.2M
Other non cash items -190.40%-248K-695.68%-85.4K---10.73K------------4.38%14.3M5.88%3.6M2.70%3.8M0.00%3.5M
Change In working capital -15.02%-585.37K50.30%-508.95K-285.19%-1.02M624.91%552.98K--76.28K--031.16%-46.4M85.23%32.6M67.67%-32.3M-220.35%-148M
-Change in receivables ---------------------------27.7M---111.3M107.55%22M-341.86%-38M
-Change in inventory -------------------------186.67%-1.3M325.00%900K-70.00%600K-300.00%-400K
-Change in prepaid assets -269.01%-85.42K77.88%-23.15K-1,237.23%-104.63K58.20%-7.82K---18.72K--0-44.00%-3.6M-28.33%4.3M4,300.00%4.2M-252.38%-7.4M
-Change in payables and accrued expense -1,961.26%-34.88K100.38%1.87K-187.20%-489.03K490.32%560.8K--95K--0115.65%6.7M16.45%106.2M70.31%-21.2M-2,203.03%-76M
-Change in other current liabilities 4.63%-465.07K-13.30%-487.67K---430.42K--0--0--------------------
-Change in other working capital ------------------------13.14%-20.5M-0.31%32.5M7.56%-37.9M19.14%-26.2M
Cash from discontinued investing activities
Operating cash flow 19.37%-4M5.77%-4.96M-586.43%-5.27M-5.61%-767.31K-85.83%-726.57K---390.99K-0.15%409.9M-5.10%154.3M425.27%47.8M-172.07%-41.8M
Investing cash flow
Cash flow from continuing investing activities 8,789.12%5.24M100.55%58.98K-10.78M0-117.84K0
Capital expenditure reported -------------------------16.52%-250.4M-25.25%-74.9M-8.37%-71.2M-2.23%-59.6M
Net PPE purchase and sale 79.65%-5.38K96.62%-26.42K---780.88K--0---117.84K--0----------------
Net business purchase and sale -------------------------1,164.23%-173.2M290.00%9.5M90.00%-400K-4,415.00%-180.6M
Net investment purchase and sale 6,045.20%5.25M100.85%85.4K---10M--0--0--------------10.3M--0
Net other investing changes ------------------------828.57%13M-7,400.00%-7.3M--8.5M--0
Cash from discontinued investing activities
Investing cash flow 8,789.12%5.24M100.55%58.98K---10.78M--0---117.84K--0-83.63%-410.6M-12.36%-72.7M24.25%-52.8M-285.55%-240.2M
Financing cash flow
Cash flow from continuing financing activities -24.19%102.28K-99.40%134.91K4,995.12%22.41M-55.50%439.75K105.43%988.08K480.99K
Net issuance payments of debt --0--0-170.58%-431.97K-38.06%612.06K105.43%988.08K--480.99K682.95%126.5M-65.96%-7.8M8.57%-6.4M4,829.03%146.6M
Net common stock issuance --0--0--22.67M--0--0--------------------
Cash dividends paid ------------------------0.00%-138.9M0.00%-34.5M-0.29%-34.6M0.00%-34.5M
Net other financing activities -24.19%102.28K-17.74%134.91K195.18%164K---172.31K---------866.67%-4.6M--0--0-270.00%-3.4M
Cash from discontinued financing activities
Financing cash flow -24.19%102.28K-99.40%134.91K4,995.12%22.41M-55.50%439.75K105.43%988.08K--480.99K89.38%-17M-10.44%-42.3M-0.99%-41M405.34%108.7M
Net cash flow
Beginning cash position -75.61%1.56M10,700.66%6.42M-84.65%59.41K59.05%386.98K58.71%243.31K--153.3K12.25%246.5M1.39%189.5M-18.26%235.5M24.63%408.8M
Current changes in cash 128.17%1.34M-175.01%-4.77M2,040.86%6.36M-328.00%-327.57K59.63%143.67K--90K-165.80%-17.7M-34.06%39.3M54.55%-46M-334.34%-173.3M
Effect of exchange rate changes 164.01%53.22K---83.15K--0--0------------------------
End cash Position 89.24%2.96M-75.61%1.56M10,700.66%6.42M-84.65%59.41K59.05%386.98K--243.31K-7.18%228.8M-7.18%228.8M1.39%189.5M-18.26%235.5M
Free cash flow 19.70%-4.01M17.49%-4.99M-688.20%-6.05M9.13%-767.31K-115.97%-844.41K---390.99K-18.46%159.5M-22.76%79.4M58.66%-23.4M-33,700.00%-101.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion with Explanatory Notes----------

Market Insights

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.